tert-Butyl 4-Formylbenzoate>98.0%(GC)1g

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

methyl 2-(6-ethyl-2-iminobenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 500mg

Dibenzo[b,e]oxepin-11(6H)-one, 95.0%, 10g

5-(chloromethyl)-3-(methoxymethyl)-1,2,4-oxadiazole, 95.0%, 5g

(R)-3-Chloro-1,2-propanediol, 95.0%, 10g

2-Ethynylphenol, 95.0%, 250mg

(2-Bromophenylethynyl)trimethylsilane>98.0%(GC)5g

7-Bromo-1H-indole-6-carboxamide, 97%, 100mg

Methacrylic Anhydride [stabilized with 1,1,3-Tris(3-tert-butyl-4-hydroxy-6-methylphenyl)butane]>97.0%(GC)(T)500g

Cryogenic vials 10 ml sterile, 50 Piece(s)

3-Chloropropyltriethoxysilane, 97%, 100g

11-Oxa-2,7,9-triazadodec-7-enoic acid, 3-carboxy-10-oxo-12-phenyl-8-[[(phenylmethoxy)carbonyl]amino]-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)-, 100mg